SlideShare a Scribd company logo
Prof. Shaikh Abusufiyan
Part-01:Patient Compliance
Pharma Learning
At the end of this e-learning session you are able to…
A. Define patient Non-compliance.
B. Discuss effect of poor compliance, method
of assessment and reasons for non-compliance.
2
l Safe and effective drug therapy occurs
when patients are well informed about
their medications and their use.
l Well inform patients exhibit:
- Increase compliance with drug regimens
Result in improved therapeutic outcomes
l Therefore, pharmacist and other health care professionals have a
responsibility --> to properly inform patients about their drug
therapy.
Non-compliance
l When patient does not follow the treatment schedule suggested
by the physician for the management of illness
he is described as non-compliant.
l Non compliant behaviour
also encompasses failure to obey instructions on:
- Diet
- Exercise
- Smoking or drinking habits.
l Degree of non compliance is expressed as a % of the ideal
compliance:
% compliance= NDP - NME * 100
NDP
l Where, NDP = No of doses prescribed
NME= No of medication error
Effect of Poor Compliance
l Poor compliance have serious effect in some
disease conditions:
- Non compliance with anticonvulsant therapy -->
contributes to uncontrolled seizures
- Omission of few doses of insulin --> may be life
threatening.
- Unintentional overdose result in --> toxicity,
serious enough to require hospitalisation.
Q&A
Q.1 When safe and effective drug therapy
occur?
Q.2 Enlist few effects of poor compliance.
8
Method of assessment of compliance
1. Interrogation:
l With the use of standard questionnaire:
- it is possible to assess the compliance
level and aspects such as:
- inconvenience of the regimen
- incidence of SE
- and overall level of comprehension.
2. Residual Tablet Counting:
- Tablet count can be performed on
regular basis and comparative no of
used tab over a period can be noted
down.
Disadvantage:
l Such methods are subjective and
inaccurate.
3. Urine analysis:
- Ex. Urine marker like riboflavin --> may be added in the
dosage regimen and its presence in the urine --> may be
noted for more accurate assessment of compliance.
4. Drug analysis:
- Specific and sensitive methods ----> to detect potent
therapeutic agent in body fluids, like digoxin and phenytoin.
l Cpss = F * D
Cl * T
l Cpss = Steady state concentration
F= Bioavailability
D= Dose administered
T= Dosage interval
Cl= Drug clearance
l The dose input rate (FD/T) may be
calculated as:
FD/T= Cpss * Cl
l Determination of plasma conc. of the
drug ---> give most accurate and
direct indication of the dose
administered.
Reference:
q Dr. H.P.Tipnis and Dr. Amrita Bajaj. Clinical Pharmacy, 3rd
edition. Carrier Publication Pg. No:86-105.
Q&A
Quiz-Attendance/Feedback:
https:/
/forms.gle/2zhTaYATheRTLQhG9
1
5
6
Prof. Shaikh Abusufiyan
Part-02:Patient Compliance
Pharma Learning
At the end of this e-learning session you are able to…
A. Explain the reason for patient Non-compliance.
B. Discuss strategies to overcome patient non-
compliance.
8
Reasons for Non-compliance
l The reason for non compliant behaviour --> are complex and cannot be generalised.
l Almost every patient --> is potential defaulter.
Reasons:
1. Poor standards of labelling:
- Label on medication containers must be clear and specific.
- Many patients do not understand common labelling instructions
ex. “Take as required” or “use as directed”
- Poorly hand written labels with bad hand writing are a major source of
medication error.
2. Inappropriate packing:
- Many elderly patients have difficulty
in opening the container --> specially
if size is too small or cap is difficult
to unscrew.
- The blister pack may be --> too rigid
- Glass bottle may be very fragile --->
making handling difficult
3. Complex therapeutic regimen:
- In case where patient have to take 25-30 different drugs at varying
time interval during day
Dosage regimens are difficult to memorize and lead to unintentional
non-compliance.
4. Nature of medication:
- Preparation with an unpleasant taste, colour or odour
- Extremely small tab ---> difficult to identify and handle
- Very large tab ---> difficult to swallow
- Liquid dosage form ---> difficult to transport
- Irritational side effect
5.Deliberate deviation:
- Once patient begin to feel better --> treatment may be stopped.
- Improper or insufficient advise --> given to patients
- At a time, lack of proper physician–pharmacist rapport
may also be responsible for non- compliant behaviour.
- Some time due to mental diseases -->
patient may forget to take an
occasional dose of medication.
- Doses may be completely omitted or
duplicated due to forgetfulness
Q&A
Q.1 Give one example of how poor standards of labelling
may be responsible for patient non-compliance?
Q.2 In which case patient non-compliance is due to
deliberate deviation?
5
Strategies for Improving Compliance
1. Simplification of the therapeutic regimen:
• Minimizing the complexity of therapeutic regimens
• Physician must prescribe a minimum number of drugs with well
define dosage schedules.
• Once daily dosage may be recommended whenever possible
(Sustained release, long acting oral preparation)
2. Improving standard of dispensing practice:
• Appropriate container size
can be selected
to accommodate a label, bearing dosage instructions
2. Improving standard of dispensing practice:
q Dosing Instructions must be:
• precise, explicit and large
• easily ridable
• Most satisfying container for elderly is palm
sized transparent bottle with standard soft
plastic screw cap.
• Child resistant containers should be used with
discretion.
3. Development of suitable
medication packaging:
- Packaging in general should help self
monitoring of drug intake.
- Ex. Blister or unit dose packaging
q Medication box: which is divided into
sections --> according to the days of the
week.
q Individual drugs are given in
compartments --> corresponding to the
time of administration. NEW START UP IDEA
https://www.dreamit.com/journal/fell
ow-launches-connected-pillbox
4. Supplementary Labelling:
q Supplementary labelling instructions --> are
recommended to convey important data
regarding drug administration.
q The information may include:
l Precaution or recommendation
l Description of drug action.
l Supplementary Labelling:
l Symbol or graphics --> may be used to
emphasise the correct time of
administration.
l A 'daily calendar' or a tablet
identification card --> bearing details of
the administration schedule may be given
to improve compliance.
Reference:
q Dr. H.P.Tipnis and Dr. Amrita Bajaj. Clinical Pharmacy, 3rd
edition. Carrier Publication Pg. No:86-105.
Q&A
Quiz-Attendance/Feedback:
https:/
/forms.gle/sjRvLKEd9EUUV3466
3
4
5
Prof. Shaikh Abusufiyan
Part-03:Patient Compliance
Pharma Learning
At the end of this e-learning session you are able to…
A. Explain role of patient counselling for improving
patient compliance.
B. Demonstrate the knowledge of precautions, directions
for medications & administration instructions to improve
patient compliance.
7
Patient counselling and education
q The pharmacist should inform, educate
and counsel the patient about:
l Name
l Intended use and expected action
l Route, dosage form, administration schedule
l Special direction for preparation if any
l Precaution to be observed during administration
l Common SE
l Technique for self monitoring of drug therapy
l Storage
• Potential drug-drug or drug-food interaction
• Prescription refill information
• Action to be taken in the event of missed dose
• Selection of non prescription drug i.e OTC drug
l Depend on the type and extend of advice needed.
l It can be given in following forms:
1. Verbal counselling
2. Printed information including
o Warning card
o Individualised medication instruction sheets
o Leaflets and booklets describing drugs and
disease conditions
o Patient package insert given by manufacturer
The method of imparting patient education and counselling
3. In patient medication training program
4. Compliance clinics --> to educate patient
identified to be non-compliant.
l The pharmacist with good communication
skill and practical experience --> can
counsel the patients
q The routine counselling of all patients is
both undesirable and impractical.
q Priority should be given to cases where:
§ Prophylactic treatment
§ Drug with low safety margin (ex. Warfarin)
§ Premature withdrawal from treatment (ex.
Corticosteroids)
§ Long term therapy (for a chronic condition) (ex.
epilepsy)
Q&A
Q.1 Which information pharmacist impart to patient as
a part of patient counseling & education?
Q.2 What are different methods of imparting patient
education and counselling?
Q.3 In which case priority is given to patient
counselling?
3
Important think that is to be kept in mind???????
q Information should be conveyed in
a manner in which:
• The patient can understand and
comprehend.
• Common language and familiar term
should be used in a style which is
reassuring rather than threatening.
Precautions and Directions for Medications and
Administration Instructions
l It is to be conveyed to the patient by the Pharmacist.
IT WILL HELP TO
Reduce no of patients who do not take their prescribed
medication correctly
q Disease state:
• Type of counselling and degree of
instructions ----> influenced by the
particular disease state.
• Extend of counselling is depend on --->
the severity and risk factors.
q Attention should be drawn to:
l Precautions
l Indications and contraindications
l Adverse reactions
l Drug interaction
l And sign and symptoms to watch for promoting
safe use of drug
Ex. Diabetes patient must understand:
§ Important of maintaining treatment
schedule.
§ Proper diet and precaution in taking other
medicines.
§ Necessary storage precaution for the insulin
§ Need of sterile syringe.
q OTC products:
• Purchased even without consulting doctor.
• Pharmacist must help patient in selection of
OTC products
• Ex. Aspirin, Antacids and Vitamins
q Pharmacist must ensure their proper use by asking questions like:
§ “Are you aware that excessive use of
l antacids can lead to alkalosis?
l Laxative can lead to loss of intestinal tone?
• Or “if you are a cardiac patient”:
l do you know that high content of alkali is undesirable for your
condition and that you have to be on low salt diet?
q Printed drug information:
• Oral instructions are recommended to be
reinforced with additional printed information.
• Patient taking special categories of drugs
such as anti-coagulant and MAO inhibitors
should be given warning cards at the time of
dispensing
Reference:
q Dr. H.P.Tipnis and Dr. Amrita Bajaj. Clinical Pharmacy, 3rd
edition. Carrier Publication Pg. No:86-105.
Q&A
Quiz-Attendance/Feedback:
https:/
/forms.gle/1mSf6hijNyRYmLD6A
5
3
4

More Related Content

What's hot

Transdermal drug delivery system
Transdermal drug delivery systemTransdermal drug delivery system
Transdermal drug delivery system
Rahul Shirode
 
Pharmaceutical polymers
Pharmaceutical polymersPharmaceutical polymers
Pharmaceutical polymers
Protik Biswas
 
Factors affecting design of Controlled Release Drug Delivery Systems (write-up)
Factors affecting design of Controlled Release Drug Delivery Systems (write-up)Factors affecting design of Controlled Release Drug Delivery Systems (write-up)
Factors affecting design of Controlled Release Drug Delivery Systems (write-up)
Suraj Choudhary
 
coacervation-phase separation technique in micro encapsulation
coacervation-phase separation technique in micro encapsulation  coacervation-phase separation technique in micro encapsulation
coacervation-phase separation technique in micro encapsulation
Tejaswini Naredla
 
Drug Absorption from the Gastrointestinal Tract
Drug Absorption from the Gastrointestinal TractDrug Absorption from the Gastrointestinal Tract
Drug Absorption from the Gastrointestinal Tract
Feba Elsa Mathew
 
Approaches Of Gastro-Retentive Drug Delivery System or GRDDS
Approaches Of Gastro-Retentive Drug Delivery System or GRDDSApproaches Of Gastro-Retentive Drug Delivery System or GRDDS
Approaches Of Gastro-Retentive Drug Delivery System or GRDDS
AkshayPatane
 
Implantable Drug Delivery System
Implantable Drug Delivery SystemImplantable Drug Delivery System
Implantable Drug Delivery System
paresh bharodiya
 
IVIVC
IVIVCIVIVC
Liposomes
LiposomesLiposomes
Liposomes
Arshad Khan
 
Measurement of bioavailability
Measurement of bioavailabilityMeasurement of bioavailability
Measurement of bioavailability
shikha singh
 
Controlled release drug delivery system
Controlled release drug delivery system Controlled release drug delivery system
Controlled release drug delivery system
MOHAMMEDABDULSALAM32
 
Controlled drug delivery system
Controlled drug delivery systemControlled drug delivery system
Controlled drug delivery system
Srushti Chahande
 
Liposomes
LiposomesLiposomes
Controlled drug delivery systems
Controlled drug delivery systemsControlled drug delivery systems
Controlled drug delivery systems
Theabhi.in
 
Methods For Assesment Of Bioavailability
Methods For Assesment Of Bioavailability Methods For Assesment Of Bioavailability
Methods For Assesment Of Bioavailability
Anindya Jana
 
Mucoadhesive Drug Delivery System
Mucoadhesive Drug Delivery SystemMucoadhesive Drug Delivery System
Theories of dissolution
Theories of dissolutionTheories of dissolution
Theories of dissolution
Samiksha Sawant
 
Niosomes
NiosomesNiosomes
Niosomes
Anil Pethe
 
Implantable Drug Delivery System
Implantable Drug Delivery SystemImplantable Drug Delivery System
Implantable Drug Delivery System
Sourav Kar
 
Gastrointestinal absorption of drugs
Gastrointestinal absorption of drugsGastrointestinal absorption of drugs
Gastrointestinal absorption of drugs
Siddu K M
 

What's hot (20)

Transdermal drug delivery system
Transdermal drug delivery systemTransdermal drug delivery system
Transdermal drug delivery system
 
Pharmaceutical polymers
Pharmaceutical polymersPharmaceutical polymers
Pharmaceutical polymers
 
Factors affecting design of Controlled Release Drug Delivery Systems (write-up)
Factors affecting design of Controlled Release Drug Delivery Systems (write-up)Factors affecting design of Controlled Release Drug Delivery Systems (write-up)
Factors affecting design of Controlled Release Drug Delivery Systems (write-up)
 
coacervation-phase separation technique in micro encapsulation
coacervation-phase separation technique in micro encapsulation  coacervation-phase separation technique in micro encapsulation
coacervation-phase separation technique in micro encapsulation
 
Drug Absorption from the Gastrointestinal Tract
Drug Absorption from the Gastrointestinal TractDrug Absorption from the Gastrointestinal Tract
Drug Absorption from the Gastrointestinal Tract
 
Approaches Of Gastro-Retentive Drug Delivery System or GRDDS
Approaches Of Gastro-Retentive Drug Delivery System or GRDDSApproaches Of Gastro-Retentive Drug Delivery System or GRDDS
Approaches Of Gastro-Retentive Drug Delivery System or GRDDS
 
Implantable Drug Delivery System
Implantable Drug Delivery SystemImplantable Drug Delivery System
Implantable Drug Delivery System
 
IVIVC
IVIVCIVIVC
IVIVC
 
Liposomes
LiposomesLiposomes
Liposomes
 
Measurement of bioavailability
Measurement of bioavailabilityMeasurement of bioavailability
Measurement of bioavailability
 
Controlled release drug delivery system
Controlled release drug delivery system Controlled release drug delivery system
Controlled release drug delivery system
 
Controlled drug delivery system
Controlled drug delivery systemControlled drug delivery system
Controlled drug delivery system
 
Liposomes
LiposomesLiposomes
Liposomes
 
Controlled drug delivery systems
Controlled drug delivery systemsControlled drug delivery systems
Controlled drug delivery systems
 
Methods For Assesment Of Bioavailability
Methods For Assesment Of Bioavailability Methods For Assesment Of Bioavailability
Methods For Assesment Of Bioavailability
 
Mucoadhesive Drug Delivery System
Mucoadhesive Drug Delivery SystemMucoadhesive Drug Delivery System
Mucoadhesive Drug Delivery System
 
Theories of dissolution
Theories of dissolutionTheories of dissolution
Theories of dissolution
 
Niosomes
NiosomesNiosomes
Niosomes
 
Implantable Drug Delivery System
Implantable Drug Delivery SystemImplantable Drug Delivery System
Implantable Drug Delivery System
 
Gastrointestinal absorption of drugs
Gastrointestinal absorption of drugsGastrointestinal absorption of drugs
Gastrointestinal absorption of drugs
 

Similar to Patient compliance and assessment |Method of Assessment | Strategy to reduce patient non-compliance | Role of Pharmacist to Improve Patient Compliance

Patient compliance Pdf
Patient compliance PdfPatient compliance Pdf
Patient compliance Pdf
Asraful Islam Rayhan
 
Medication Adherence.pptx
Medication Adherence.pptxMedication Adherence.pptx
Medication Adherence.pptx
Ameena Kadar
 
patientcounselling-150101104720-conversion-gate01 (1).pdf
patientcounselling-150101104720-conversion-gate01 (1).pdfpatientcounselling-150101104720-conversion-gate01 (1).pdf
patientcounselling-150101104720-conversion-gate01 (1).pdf
HasmukhPatel63
 
Patient counselling
Patient counsellingPatient counselling
Patient counselling
Jabir Jabir
 
Patient Counselling
Patient CounsellingPatient Counselling
Patient Counselling
sunayanamali
 
medication adherence
medication adherencemedication adherence
medication adherence
Ramesh Ganpisetti
 
16 ab1t0022
16 ab1t002216 ab1t0022
16 ab1t0022
Ramesh Ganpisetti
 
Clinical Pharmacy - Patient Compliance
Clinical Pharmacy - Patient ComplianceClinical Pharmacy - Patient Compliance
Clinical Pharmacy - Patient Compliance
Devyani Joshi
 
Compliance
ComplianceCompliance
Compliance
Praveena Gungam
 
clinical pharmacy and modern dispensing practice. ...docx
clinical pharmacy and modern dispensing practice. ...docxclinical pharmacy and modern dispensing practice. ...docx
clinical pharmacy and modern dispensing practice. ...docx
Priyayannawar4
 
Patient medication counselling.
Patient medication counselling.Patient medication counselling.
Patient medication counselling.
varshawadnere
 
PATIENT COUNSELLING_RDP.pdf
PATIENT COUNSELLING_RDP.pdfPATIENT COUNSELLING_RDP.pdf
PATIENT COUNSELLING_RDP.pdf
rishi2789
 
PHARMACEUTICAL CARE.docx
PHARMACEUTICAL CARE.docxPHARMACEUTICAL CARE.docx
PHARMACEUTICAL CARE.docx
NbkKarim1
 
PATIENT COUNSELLING AND COMMUNICATION SKILLS
PATIENT COUNSELLING AND COMMUNICATION SKILLSPATIENT COUNSELLING AND COMMUNICATION SKILLS
PATIENT COUNSELLING AND COMMUNICATION SKILLS
VaishnaviJanjal
 
Medication Adherence
Medication Adherence Medication Adherence
Medication Adherence
sunayanamali
 
Medication Adherence.pdf
Medication Adherence.pdfMedication Adherence.pdf
Medication Adherence.pdf
Dr Ravikiran S
 
patient consuling.
patient consuling.patient consuling.
patient consuling.
pratikshagharat
 
RDP-PP-MA.pdf
RDP-PP-MA.pdfRDP-PP-MA.pdf
RDP-PP-MA.pdf
rishi2789
 
Patient counselling
Patient counselling Patient counselling
Patient counselling
Harshita Jain
 
Patient counselling
Patient counsellingPatient counselling
Patient counselling
KRUSHNA ZAMBARE
 

Similar to Patient compliance and assessment |Method of Assessment | Strategy to reduce patient non-compliance | Role of Pharmacist to Improve Patient Compliance (20)

Patient compliance Pdf
Patient compliance PdfPatient compliance Pdf
Patient compliance Pdf
 
Medication Adherence.pptx
Medication Adherence.pptxMedication Adherence.pptx
Medication Adherence.pptx
 
patientcounselling-150101104720-conversion-gate01 (1).pdf
patientcounselling-150101104720-conversion-gate01 (1).pdfpatientcounselling-150101104720-conversion-gate01 (1).pdf
patientcounselling-150101104720-conversion-gate01 (1).pdf
 
Patient counselling
Patient counsellingPatient counselling
Patient counselling
 
Patient Counselling
Patient CounsellingPatient Counselling
Patient Counselling
 
medication adherence
medication adherencemedication adherence
medication adherence
 
16 ab1t0022
16 ab1t002216 ab1t0022
16 ab1t0022
 
Clinical Pharmacy - Patient Compliance
Clinical Pharmacy - Patient ComplianceClinical Pharmacy - Patient Compliance
Clinical Pharmacy - Patient Compliance
 
Compliance
ComplianceCompliance
Compliance
 
clinical pharmacy and modern dispensing practice. ...docx
clinical pharmacy and modern dispensing practice. ...docxclinical pharmacy and modern dispensing practice. ...docx
clinical pharmacy and modern dispensing practice. ...docx
 
Patient medication counselling.
Patient medication counselling.Patient medication counselling.
Patient medication counselling.
 
PATIENT COUNSELLING_RDP.pdf
PATIENT COUNSELLING_RDP.pdfPATIENT COUNSELLING_RDP.pdf
PATIENT COUNSELLING_RDP.pdf
 
PHARMACEUTICAL CARE.docx
PHARMACEUTICAL CARE.docxPHARMACEUTICAL CARE.docx
PHARMACEUTICAL CARE.docx
 
PATIENT COUNSELLING AND COMMUNICATION SKILLS
PATIENT COUNSELLING AND COMMUNICATION SKILLSPATIENT COUNSELLING AND COMMUNICATION SKILLS
PATIENT COUNSELLING AND COMMUNICATION SKILLS
 
Medication Adherence
Medication Adherence Medication Adherence
Medication Adherence
 
Medication Adherence.pdf
Medication Adherence.pdfMedication Adherence.pdf
Medication Adherence.pdf
 
patient consuling.
patient consuling.patient consuling.
patient consuling.
 
RDP-PP-MA.pdf
RDP-PP-MA.pdfRDP-PP-MA.pdf
RDP-PP-MA.pdf
 
Patient counselling
Patient counselling Patient counselling
Patient counselling
 
Patient counselling
Patient counsellingPatient counselling
Patient counselling
 

More from Shaikh Abusufyan

PHARMACOKINETIC- ABSORPTION, DISTRIBUTION (1) [Autosaved].pptx
PHARMACOKINETIC- ABSORPTION, DISTRIBUTION  (1) [Autosaved].pptxPHARMACOKINETIC- ABSORPTION, DISTRIBUTION  (1) [Autosaved].pptx
PHARMACOKINETIC- ABSORPTION, DISTRIBUTION (1) [Autosaved].pptx
Shaikh Abusufyan
 
antiprotozoal_Antimalarial_drugs.pdf
antiprotozoal_Antimalarial_drugs.pdfantiprotozoal_Antimalarial_drugs.pdf
antiprotozoal_Antimalarial_drugs.pdf
Shaikh Abusufyan
 
Neurohumoral Transmission.pdf
Neurohumoral Transmission.pdfNeurohumoral Transmission.pdf
Neurohumoral Transmission.pdf
Shaikh Abusufyan
 
Drug Excretion.pdf
Drug Excretion.pdfDrug Excretion.pdf
Drug Excretion.pdf
Shaikh Abusufyan
 
Anthelmintics drugs.pdf
Anthelmintics drugs.pdfAnthelmintics drugs.pdf
Anthelmintics drugs.pdf
Shaikh Abusufyan
 
Drug metabolism.pdf
Drug metabolism.pdfDrug metabolism.pdf
Drug metabolism.pdf
Shaikh Abusufyan
 
Drug Distribution.pdf
Drug Distribution.pdfDrug Distribution.pdf
Drug Distribution.pdf
Shaikh Abusufyan
 
Absorption, Bioavailability and Bioequivalance.pdf
Absorption, Bioavailability and Bioequivalance.pdfAbsorption, Bioavailability and Bioequivalance.pdf
Absorption, Bioavailability and Bioequivalance.pdf
Shaikh Abusufyan
 
Anti-fungal drugs.pdf
Anti-fungal drugs.pdfAnti-fungal drugs.pdf
Anti-fungal drugs.pdf
Shaikh Abusufyan
 
Agonists and Antagonist.pdf
Agonists and Antagonist.pdfAgonists and Antagonist.pdf
Agonists and Antagonist.pdf
Shaikh Abusufyan
 
Macrolides.pdf
Macrolides.pdfMacrolides.pdf
Macrolides.pdf
Shaikh Abusufyan
 
Chemotherapy_Chloramphenicol.pdf
Chemotherapy_Chloramphenicol.pdfChemotherapy_Chloramphenicol.pdf
Chemotherapy_Chloramphenicol.pdf
Shaikh Abusufyan
 
CHEMOTHERAPY_Cephalosporin.pdf
CHEMOTHERAPY_Cephalosporin.pdfCHEMOTHERAPY_Cephalosporin.pdf
CHEMOTHERAPY_Cephalosporin.pdf
Shaikh Abusufyan
 
Routs of drug administration.pptx
Routs of drug administration.pptxRouts of drug administration.pptx
Routs of drug administration.pptx
Shaikh Abusufyan
 
Introduction to Pharmacol.pdf
Introduction to Pharmacol.pdfIntroduction to Pharmacol.pdf
Introduction to Pharmacol.pdf
Shaikh Abusufyan
 
Nasal decongestants and Respiratory Stimulants.pdf
Nasal decongestants and Respiratory Stimulants.pdfNasal decongestants and Respiratory Stimulants.pdf
Nasal decongestants and Respiratory Stimulants.pdf
Shaikh Abusufyan
 
Antibiotics: Penicillin.pdf
Antibiotics: Penicillin.pdfAntibiotics: Penicillin.pdf
Antibiotics: Penicillin.pdf
Shaikh Abusufyan
 
Adverse drug reactions.pdf
Adverse drug reactions.pdfAdverse drug reactions.pdf
Adverse drug reactions.pdf
Shaikh Abusufyan
 
Pharmacoeconomics
PharmacoeconomicsPharmacoeconomics
Pharmacoeconomics
Shaikh Abusufyan
 
Pharmacoepidemiology
PharmacoepidemiologyPharmacoepidemiology
Pharmacoepidemiology
Shaikh Abusufyan
 

More from Shaikh Abusufyan (20)

PHARMACOKINETIC- ABSORPTION, DISTRIBUTION (1) [Autosaved].pptx
PHARMACOKINETIC- ABSORPTION, DISTRIBUTION  (1) [Autosaved].pptxPHARMACOKINETIC- ABSORPTION, DISTRIBUTION  (1) [Autosaved].pptx
PHARMACOKINETIC- ABSORPTION, DISTRIBUTION (1) [Autosaved].pptx
 
antiprotozoal_Antimalarial_drugs.pdf
antiprotozoal_Antimalarial_drugs.pdfantiprotozoal_Antimalarial_drugs.pdf
antiprotozoal_Antimalarial_drugs.pdf
 
Neurohumoral Transmission.pdf
Neurohumoral Transmission.pdfNeurohumoral Transmission.pdf
Neurohumoral Transmission.pdf
 
Drug Excretion.pdf
Drug Excretion.pdfDrug Excretion.pdf
Drug Excretion.pdf
 
Anthelmintics drugs.pdf
Anthelmintics drugs.pdfAnthelmintics drugs.pdf
Anthelmintics drugs.pdf
 
Drug metabolism.pdf
Drug metabolism.pdfDrug metabolism.pdf
Drug metabolism.pdf
 
Drug Distribution.pdf
Drug Distribution.pdfDrug Distribution.pdf
Drug Distribution.pdf
 
Absorption, Bioavailability and Bioequivalance.pdf
Absorption, Bioavailability and Bioequivalance.pdfAbsorption, Bioavailability and Bioequivalance.pdf
Absorption, Bioavailability and Bioequivalance.pdf
 
Anti-fungal drugs.pdf
Anti-fungal drugs.pdfAnti-fungal drugs.pdf
Anti-fungal drugs.pdf
 
Agonists and Antagonist.pdf
Agonists and Antagonist.pdfAgonists and Antagonist.pdf
Agonists and Antagonist.pdf
 
Macrolides.pdf
Macrolides.pdfMacrolides.pdf
Macrolides.pdf
 
Chemotherapy_Chloramphenicol.pdf
Chemotherapy_Chloramphenicol.pdfChemotherapy_Chloramphenicol.pdf
Chemotherapy_Chloramphenicol.pdf
 
CHEMOTHERAPY_Cephalosporin.pdf
CHEMOTHERAPY_Cephalosporin.pdfCHEMOTHERAPY_Cephalosporin.pdf
CHEMOTHERAPY_Cephalosporin.pdf
 
Routs of drug administration.pptx
Routs of drug administration.pptxRouts of drug administration.pptx
Routs of drug administration.pptx
 
Introduction to Pharmacol.pdf
Introduction to Pharmacol.pdfIntroduction to Pharmacol.pdf
Introduction to Pharmacol.pdf
 
Nasal decongestants and Respiratory Stimulants.pdf
Nasal decongestants and Respiratory Stimulants.pdfNasal decongestants and Respiratory Stimulants.pdf
Nasal decongestants and Respiratory Stimulants.pdf
 
Antibiotics: Penicillin.pdf
Antibiotics: Penicillin.pdfAntibiotics: Penicillin.pdf
Antibiotics: Penicillin.pdf
 
Adverse drug reactions.pdf
Adverse drug reactions.pdfAdverse drug reactions.pdf
Adverse drug reactions.pdf
 
Pharmacoeconomics
PharmacoeconomicsPharmacoeconomics
Pharmacoeconomics
 
Pharmacoepidemiology
PharmacoepidemiologyPharmacoepidemiology
Pharmacoepidemiology
 

Recently uploaded

S1-Introduction-Biopesticides in ICM.pptx
S1-Introduction-Biopesticides in ICM.pptxS1-Introduction-Biopesticides in ICM.pptx
S1-Introduction-Biopesticides in ICM.pptx
tarandeep35
 
How to Make a Field Mandatory in Odoo 17
How to Make a Field Mandatory in Odoo 17How to Make a Field Mandatory in Odoo 17
How to Make a Field Mandatory in Odoo 17
Celine George
 
DRUGS AND ITS classification slide share
DRUGS AND ITS classification slide shareDRUGS AND ITS classification slide share
DRUGS AND ITS classification slide share
taiba qazi
 
The simplified electron and muon model, Oscillating Spacetime: The Foundation...
The simplified electron and muon model, Oscillating Spacetime: The Foundation...The simplified electron and muon model, Oscillating Spacetime: The Foundation...
The simplified electron and muon model, Oscillating Spacetime: The Foundation...
RitikBhardwaj56
 
RPMS TEMPLATE FOR SCHOOL YEAR 2023-2024 FOR TEACHER 1 TO TEACHER 3
RPMS TEMPLATE FOR SCHOOL YEAR 2023-2024 FOR TEACHER 1 TO TEACHER 3RPMS TEMPLATE FOR SCHOOL YEAR 2023-2024 FOR TEACHER 1 TO TEACHER 3
RPMS TEMPLATE FOR SCHOOL YEAR 2023-2024 FOR TEACHER 1 TO TEACHER 3
IreneSebastianRueco1
 
LAND USE LAND COVER AND NDVI OF MIRZAPUR DISTRICT, UP
LAND USE LAND COVER AND NDVI OF MIRZAPUR DISTRICT, UPLAND USE LAND COVER AND NDVI OF MIRZAPUR DISTRICT, UP
LAND USE LAND COVER AND NDVI OF MIRZAPUR DISTRICT, UP
RAHUL
 
writing about opinions about Australia the movie
writing about opinions about Australia the moviewriting about opinions about Australia the movie
writing about opinions about Australia the movie
Nicholas Montgomery
 
Exploiting Artificial Intelligence for Empowering Researchers and Faculty, In...
Exploiting Artificial Intelligence for Empowering Researchers and Faculty, In...Exploiting Artificial Intelligence for Empowering Researchers and Faculty, In...
Exploiting Artificial Intelligence for Empowering Researchers and Faculty, In...
Dr. Vinod Kumar Kanvaria
 
Film vocab for eal 3 students: Australia the movie
Film vocab for eal 3 students: Australia the movieFilm vocab for eal 3 students: Australia the movie
Film vocab for eal 3 students: Australia the movie
Nicholas Montgomery
 
Pollock and Snow "DEIA in the Scholarly Landscape, Session One: Setting Expec...
Pollock and Snow "DEIA in the Scholarly Landscape, Session One: Setting Expec...Pollock and Snow "DEIA in the Scholarly Landscape, Session One: Setting Expec...
Pollock and Snow "DEIA in the Scholarly Landscape, Session One: Setting Expec...
National Information Standards Organization (NISO)
 
Digital Artifact 1 - 10VCD Environments Unit
Digital Artifact 1 - 10VCD Environments UnitDigital Artifact 1 - 10VCD Environments Unit
Digital Artifact 1 - 10VCD Environments Unit
chanes7
 
ISO/IEC 27001, ISO/IEC 42001, and GDPR: Best Practices for Implementation and...
ISO/IEC 27001, ISO/IEC 42001, and GDPR: Best Practices for Implementation and...ISO/IEC 27001, ISO/IEC 42001, and GDPR: Best Practices for Implementation and...
ISO/IEC 27001, ISO/IEC 42001, and GDPR: Best Practices for Implementation and...
PECB
 
Pengantar Penggunaan Flutter - Dart programming language1.pptx
Pengantar Penggunaan Flutter - Dart programming language1.pptxPengantar Penggunaan Flutter - Dart programming language1.pptx
Pengantar Penggunaan Flutter - Dart programming language1.pptx
Fajar Baskoro
 
Main Java[All of the Base Concepts}.docx
Main Java[All of the Base Concepts}.docxMain Java[All of the Base Concepts}.docx
Main Java[All of the Base Concepts}.docx
adhitya5119
 
The History of Stoke Newington Street Names
The History of Stoke Newington Street NamesThe History of Stoke Newington Street Names
The History of Stoke Newington Street Names
History of Stoke Newington
 
How to Add Chatter in the odoo 17 ERP Module
How to Add Chatter in the odoo 17 ERP ModuleHow to Add Chatter in the odoo 17 ERP Module
How to Add Chatter in the odoo 17 ERP Module
Celine George
 
BÀI TẬP BỔ TRỢ TIẾNG ANH 8 CẢ NĂM - GLOBAL SUCCESS - NĂM HỌC 2023-2024 (CÓ FI...
BÀI TẬP BỔ TRỢ TIẾNG ANH 8 CẢ NĂM - GLOBAL SUCCESS - NĂM HỌC 2023-2024 (CÓ FI...BÀI TẬP BỔ TRỢ TIẾNG ANH 8 CẢ NĂM - GLOBAL SUCCESS - NĂM HỌC 2023-2024 (CÓ FI...
BÀI TẬP BỔ TRỢ TIẾNG ANH 8 CẢ NĂM - GLOBAL SUCCESS - NĂM HỌC 2023-2024 (CÓ FI...
Nguyen Thanh Tu Collection
 
PIMS Job Advertisement 2024.pdf Islamabad
PIMS Job Advertisement 2024.pdf IslamabadPIMS Job Advertisement 2024.pdf Islamabad
PIMS Job Advertisement 2024.pdf Islamabad
AyyanKhan40
 
clinical examination of hip joint (1).pdf
clinical examination of hip joint (1).pdfclinical examination of hip joint (1).pdf
clinical examination of hip joint (1).pdf
Priyankaranawat4
 
Smart-Money for SMC traders good time and ICT
Smart-Money for SMC traders good time and ICTSmart-Money for SMC traders good time and ICT
Smart-Money for SMC traders good time and ICT
simonomuemu
 

Recently uploaded (20)

S1-Introduction-Biopesticides in ICM.pptx
S1-Introduction-Biopesticides in ICM.pptxS1-Introduction-Biopesticides in ICM.pptx
S1-Introduction-Biopesticides in ICM.pptx
 
How to Make a Field Mandatory in Odoo 17
How to Make a Field Mandatory in Odoo 17How to Make a Field Mandatory in Odoo 17
How to Make a Field Mandatory in Odoo 17
 
DRUGS AND ITS classification slide share
DRUGS AND ITS classification slide shareDRUGS AND ITS classification slide share
DRUGS AND ITS classification slide share
 
The simplified electron and muon model, Oscillating Spacetime: The Foundation...
The simplified electron and muon model, Oscillating Spacetime: The Foundation...The simplified electron and muon model, Oscillating Spacetime: The Foundation...
The simplified electron and muon model, Oscillating Spacetime: The Foundation...
 
RPMS TEMPLATE FOR SCHOOL YEAR 2023-2024 FOR TEACHER 1 TO TEACHER 3
RPMS TEMPLATE FOR SCHOOL YEAR 2023-2024 FOR TEACHER 1 TO TEACHER 3RPMS TEMPLATE FOR SCHOOL YEAR 2023-2024 FOR TEACHER 1 TO TEACHER 3
RPMS TEMPLATE FOR SCHOOL YEAR 2023-2024 FOR TEACHER 1 TO TEACHER 3
 
LAND USE LAND COVER AND NDVI OF MIRZAPUR DISTRICT, UP
LAND USE LAND COVER AND NDVI OF MIRZAPUR DISTRICT, UPLAND USE LAND COVER AND NDVI OF MIRZAPUR DISTRICT, UP
LAND USE LAND COVER AND NDVI OF MIRZAPUR DISTRICT, UP
 
writing about opinions about Australia the movie
writing about opinions about Australia the moviewriting about opinions about Australia the movie
writing about opinions about Australia the movie
 
Exploiting Artificial Intelligence for Empowering Researchers and Faculty, In...
Exploiting Artificial Intelligence for Empowering Researchers and Faculty, In...Exploiting Artificial Intelligence for Empowering Researchers and Faculty, In...
Exploiting Artificial Intelligence for Empowering Researchers and Faculty, In...
 
Film vocab for eal 3 students: Australia the movie
Film vocab for eal 3 students: Australia the movieFilm vocab for eal 3 students: Australia the movie
Film vocab for eal 3 students: Australia the movie
 
Pollock and Snow "DEIA in the Scholarly Landscape, Session One: Setting Expec...
Pollock and Snow "DEIA in the Scholarly Landscape, Session One: Setting Expec...Pollock and Snow "DEIA in the Scholarly Landscape, Session One: Setting Expec...
Pollock and Snow "DEIA in the Scholarly Landscape, Session One: Setting Expec...
 
Digital Artifact 1 - 10VCD Environments Unit
Digital Artifact 1 - 10VCD Environments UnitDigital Artifact 1 - 10VCD Environments Unit
Digital Artifact 1 - 10VCD Environments Unit
 
ISO/IEC 27001, ISO/IEC 42001, and GDPR: Best Practices for Implementation and...
ISO/IEC 27001, ISO/IEC 42001, and GDPR: Best Practices for Implementation and...ISO/IEC 27001, ISO/IEC 42001, and GDPR: Best Practices for Implementation and...
ISO/IEC 27001, ISO/IEC 42001, and GDPR: Best Practices for Implementation and...
 
Pengantar Penggunaan Flutter - Dart programming language1.pptx
Pengantar Penggunaan Flutter - Dart programming language1.pptxPengantar Penggunaan Flutter - Dart programming language1.pptx
Pengantar Penggunaan Flutter - Dart programming language1.pptx
 
Main Java[All of the Base Concepts}.docx
Main Java[All of the Base Concepts}.docxMain Java[All of the Base Concepts}.docx
Main Java[All of the Base Concepts}.docx
 
The History of Stoke Newington Street Names
The History of Stoke Newington Street NamesThe History of Stoke Newington Street Names
The History of Stoke Newington Street Names
 
How to Add Chatter in the odoo 17 ERP Module
How to Add Chatter in the odoo 17 ERP ModuleHow to Add Chatter in the odoo 17 ERP Module
How to Add Chatter in the odoo 17 ERP Module
 
BÀI TẬP BỔ TRỢ TIẾNG ANH 8 CẢ NĂM - GLOBAL SUCCESS - NĂM HỌC 2023-2024 (CÓ FI...
BÀI TẬP BỔ TRỢ TIẾNG ANH 8 CẢ NĂM - GLOBAL SUCCESS - NĂM HỌC 2023-2024 (CÓ FI...BÀI TẬP BỔ TRỢ TIẾNG ANH 8 CẢ NĂM - GLOBAL SUCCESS - NĂM HỌC 2023-2024 (CÓ FI...
BÀI TẬP BỔ TRỢ TIẾNG ANH 8 CẢ NĂM - GLOBAL SUCCESS - NĂM HỌC 2023-2024 (CÓ FI...
 
PIMS Job Advertisement 2024.pdf Islamabad
PIMS Job Advertisement 2024.pdf IslamabadPIMS Job Advertisement 2024.pdf Islamabad
PIMS Job Advertisement 2024.pdf Islamabad
 
clinical examination of hip joint (1).pdf
clinical examination of hip joint (1).pdfclinical examination of hip joint (1).pdf
clinical examination of hip joint (1).pdf
 
Smart-Money for SMC traders good time and ICT
Smart-Money for SMC traders good time and ICTSmart-Money for SMC traders good time and ICT
Smart-Money for SMC traders good time and ICT
 

Patient compliance and assessment |Method of Assessment | Strategy to reduce patient non-compliance | Role of Pharmacist to Improve Patient Compliance

  • 1. Prof. Shaikh Abusufiyan Part-01:Patient Compliance Pharma Learning
  • 2. At the end of this e-learning session you are able to… A. Define patient Non-compliance. B. Discuss effect of poor compliance, method of assessment and reasons for non-compliance. 2
  • 3. l Safe and effective drug therapy occurs when patients are well informed about their medications and their use. l Well inform patients exhibit: - Increase compliance with drug regimens Result in improved therapeutic outcomes
  • 4. l Therefore, pharmacist and other health care professionals have a responsibility --> to properly inform patients about their drug therapy. Non-compliance l When patient does not follow the treatment schedule suggested by the physician for the management of illness he is described as non-compliant.
  • 5. l Non compliant behaviour also encompasses failure to obey instructions on: - Diet - Exercise - Smoking or drinking habits.
  • 6. l Degree of non compliance is expressed as a % of the ideal compliance: % compliance= NDP - NME * 100 NDP l Where, NDP = No of doses prescribed NME= No of medication error
  • 7. Effect of Poor Compliance l Poor compliance have serious effect in some disease conditions: - Non compliance with anticonvulsant therapy --> contributes to uncontrolled seizures - Omission of few doses of insulin --> may be life threatening. - Unintentional overdose result in --> toxicity, serious enough to require hospitalisation.
  • 8. Q&A Q.1 When safe and effective drug therapy occur? Q.2 Enlist few effects of poor compliance. 8
  • 9. Method of assessment of compliance 1. Interrogation: l With the use of standard questionnaire: - it is possible to assess the compliance level and aspects such as: - inconvenience of the regimen - incidence of SE - and overall level of comprehension.
  • 10. 2. Residual Tablet Counting: - Tablet count can be performed on regular basis and comparative no of used tab over a period can be noted down. Disadvantage: l Such methods are subjective and inaccurate.
  • 11. 3. Urine analysis: - Ex. Urine marker like riboflavin --> may be added in the dosage regimen and its presence in the urine --> may be noted for more accurate assessment of compliance. 4. Drug analysis: - Specific and sensitive methods ----> to detect potent therapeutic agent in body fluids, like digoxin and phenytoin.
  • 12. l Cpss = F * D Cl * T l Cpss = Steady state concentration F= Bioavailability D= Dose administered T= Dosage interval Cl= Drug clearance
  • 13. l The dose input rate (FD/T) may be calculated as: FD/T= Cpss * Cl l Determination of plasma conc. of the drug ---> give most accurate and direct indication of the dose administered.
  • 14. Reference: q Dr. H.P.Tipnis and Dr. Amrita Bajaj. Clinical Pharmacy, 3rd edition. Carrier Publication Pg. No:86-105.
  • 16. 6
  • 17. Prof. Shaikh Abusufiyan Part-02:Patient Compliance Pharma Learning
  • 18. At the end of this e-learning session you are able to… A. Explain the reason for patient Non-compliance. B. Discuss strategies to overcome patient non- compliance. 8
  • 19. Reasons for Non-compliance l The reason for non compliant behaviour --> are complex and cannot be generalised. l Almost every patient --> is potential defaulter. Reasons: 1. Poor standards of labelling: - Label on medication containers must be clear and specific. - Many patients do not understand common labelling instructions ex. “Take as required” or “use as directed” - Poorly hand written labels with bad hand writing are a major source of medication error.
  • 20. 2. Inappropriate packing: - Many elderly patients have difficulty in opening the container --> specially if size is too small or cap is difficult to unscrew. - The blister pack may be --> too rigid - Glass bottle may be very fragile ---> making handling difficult
  • 21. 3. Complex therapeutic regimen: - In case where patient have to take 25-30 different drugs at varying time interval during day Dosage regimens are difficult to memorize and lead to unintentional non-compliance.
  • 22. 4. Nature of medication: - Preparation with an unpleasant taste, colour or odour - Extremely small tab ---> difficult to identify and handle - Very large tab ---> difficult to swallow - Liquid dosage form ---> difficult to transport - Irritational side effect
  • 23. 5.Deliberate deviation: - Once patient begin to feel better --> treatment may be stopped. - Improper or insufficient advise --> given to patients - At a time, lack of proper physician–pharmacist rapport may also be responsible for non- compliant behaviour.
  • 24. - Some time due to mental diseases --> patient may forget to take an occasional dose of medication. - Doses may be completely omitted or duplicated due to forgetfulness
  • 25. Q&A Q.1 Give one example of how poor standards of labelling may be responsible for patient non-compliance? Q.2 In which case patient non-compliance is due to deliberate deviation? 5
  • 26. Strategies for Improving Compliance 1. Simplification of the therapeutic regimen: • Minimizing the complexity of therapeutic regimens • Physician must prescribe a minimum number of drugs with well define dosage schedules. • Once daily dosage may be recommended whenever possible (Sustained release, long acting oral preparation)
  • 27. 2. Improving standard of dispensing practice: • Appropriate container size can be selected to accommodate a label, bearing dosage instructions
  • 28. 2. Improving standard of dispensing practice: q Dosing Instructions must be: • precise, explicit and large • easily ridable • Most satisfying container for elderly is palm sized transparent bottle with standard soft plastic screw cap. • Child resistant containers should be used with discretion.
  • 29. 3. Development of suitable medication packaging: - Packaging in general should help self monitoring of drug intake. - Ex. Blister or unit dose packaging
  • 30. q Medication box: which is divided into sections --> according to the days of the week. q Individual drugs are given in compartments --> corresponding to the time of administration. NEW START UP IDEA https://www.dreamit.com/journal/fell ow-launches-connected-pillbox
  • 31. 4. Supplementary Labelling: q Supplementary labelling instructions --> are recommended to convey important data regarding drug administration. q The information may include: l Precaution or recommendation l Description of drug action.
  • 32. l Supplementary Labelling: l Symbol or graphics --> may be used to emphasise the correct time of administration. l A 'daily calendar' or a tablet identification card --> bearing details of the administration schedule may be given to improve compliance.
  • 33. Reference: q Dr. H.P.Tipnis and Dr. Amrita Bajaj. Clinical Pharmacy, 3rd edition. Carrier Publication Pg. No:86-105.
  • 35. 5
  • 36. Prof. Shaikh Abusufiyan Part-03:Patient Compliance Pharma Learning
  • 37. At the end of this e-learning session you are able to… A. Explain role of patient counselling for improving patient compliance. B. Demonstrate the knowledge of precautions, directions for medications & administration instructions to improve patient compliance. 7
  • 38. Patient counselling and education q The pharmacist should inform, educate and counsel the patient about: l Name l Intended use and expected action l Route, dosage form, administration schedule l Special direction for preparation if any
  • 39. l Precaution to be observed during administration l Common SE l Technique for self monitoring of drug therapy l Storage • Potential drug-drug or drug-food interaction • Prescription refill information • Action to be taken in the event of missed dose • Selection of non prescription drug i.e OTC drug
  • 40. l Depend on the type and extend of advice needed. l It can be given in following forms: 1. Verbal counselling 2. Printed information including o Warning card o Individualised medication instruction sheets o Leaflets and booklets describing drugs and disease conditions o Patient package insert given by manufacturer The method of imparting patient education and counselling
  • 41. 3. In patient medication training program 4. Compliance clinics --> to educate patient identified to be non-compliant. l The pharmacist with good communication skill and practical experience --> can counsel the patients
  • 42. q The routine counselling of all patients is both undesirable and impractical. q Priority should be given to cases where: § Prophylactic treatment § Drug with low safety margin (ex. Warfarin) § Premature withdrawal from treatment (ex. Corticosteroids) § Long term therapy (for a chronic condition) (ex. epilepsy)
  • 43. Q&A Q.1 Which information pharmacist impart to patient as a part of patient counseling & education? Q.2 What are different methods of imparting patient education and counselling? Q.3 In which case priority is given to patient counselling? 3
  • 44. Important think that is to be kept in mind??????? q Information should be conveyed in a manner in which: • The patient can understand and comprehend. • Common language and familiar term should be used in a style which is reassuring rather than threatening.
  • 45. Precautions and Directions for Medications and Administration Instructions l It is to be conveyed to the patient by the Pharmacist. IT WILL HELP TO Reduce no of patients who do not take their prescribed medication correctly
  • 46. q Disease state: • Type of counselling and degree of instructions ----> influenced by the particular disease state. • Extend of counselling is depend on ---> the severity and risk factors.
  • 47. q Attention should be drawn to: l Precautions l Indications and contraindications l Adverse reactions l Drug interaction l And sign and symptoms to watch for promoting safe use of drug
  • 48. Ex. Diabetes patient must understand: § Important of maintaining treatment schedule. § Proper diet and precaution in taking other medicines. § Necessary storage precaution for the insulin § Need of sterile syringe.
  • 49. q OTC products: • Purchased even without consulting doctor. • Pharmacist must help patient in selection of OTC products • Ex. Aspirin, Antacids and Vitamins
  • 50. q Pharmacist must ensure their proper use by asking questions like: § “Are you aware that excessive use of l antacids can lead to alkalosis? l Laxative can lead to loss of intestinal tone? • Or “if you are a cardiac patient”: l do you know that high content of alkali is undesirable for your condition and that you have to be on low salt diet?
  • 51. q Printed drug information: • Oral instructions are recommended to be reinforced with additional printed information. • Patient taking special categories of drugs such as anti-coagulant and MAO inhibitors should be given warning cards at the time of dispensing
  • 52. Reference: q Dr. H.P.Tipnis and Dr. Amrita Bajaj. Clinical Pharmacy, 3rd edition. Carrier Publication Pg. No:86-105.
  • 54. 4